Special care should be taken while using urokinase if you recently have had bleeding from stomach or intestines, had surgery or had given blood recently, had heart problems, have severe blood vessel in the brain or are above 75 years of age.
Inform your doctor if you are taking medication like heparin or other anticoagulants, aspirin, non-steroidal anti-inflammatory agents (NSAIDs), dipyridamole or dextrans.
Avoid taking aspirin or ibuprofen to treat a fever after you have received urokinase as it may increase your risk of bleeding.
Avoid activities that may increase your risk of bleeding or injury.
Interaction with alcohol is unknown. Please consult your doctor.
Medinase 500000IU Injection is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Medinase 500000IU Injection is probably safe to use during l
Limited human data suggests that the drug does not represent a significant risk to the baby.
Not relevant, as Medinase 500000IU Injection is intended for use in hospitalised patients.
Medinase 500000IU Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Medinase 500000IU Injection may not be needed in these patients. Please consult your doctor.
Use of Medinase 500000IU Injection is not recommended in patients with severe kidney disease.
Medinase 500000IU Injection should be used with caution in p
atients with liver disease. Dose adjustment of Medinase 500000IU Injection may be needed. Please consult your doctor.